WHERE WE ARE
WHERE WE WORK
The Lilly MDR-TB Partnership has had direct impact in more than 80 countries, through research, training, technology transfer, advocacy and public awareness-raising. Beginning in 2012, we narrowed our geographic focus to the four countries with the highest burdens of MDR-TB: China, India, Russia and South Africa. By targeting efforts and resources where the need is greatest, we can make a deeper and lasting impact. This decision was supported by global TB
LILLY MDR-TB PARTNERSHIP ON THE GROUND
Today, the Lilly MDR-TB Partnership operates in four target countries: China, India, Russia and South Africa, focusing our geographic reach and ‘Research, Report, Advocate’ approach to have an even deeper impact where the disease is most active.
Click through to the following pages to learn what we’re doing on the ground.